Converge Bio, Inc.

Converge Bio, Inc. is a privately-held company that develops a biotech platform designed to integrate generative artificial intelligence with biological data to accelerate drug discovery and development. Converge Bio, Inc. was founded in 2024 by Dov Gertz and Oded Kalev. Converge Bio, Inc. headquarters are located in Wilmington, Delaware.

a company that develops a biotech platform designed to integrate generative artificial intelligence with biological data to accelerate drug discovery and development, raises $2.5MM Grant from Bill & Melinda Gates Foundation.

a company that develops a biotech platform designed to integrate generative artificial intelligence with biological data to accelerate drug discovery and development, raises $25MM Series A from Bessemer Venture Partners.
